Amundi’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,046
Closed -$51.1K 1887
2025
Q1
$51.1K Hold
6,046
﹤0.01% 1816
2024
Q4
$40.1K Hold
6,046
﹤0.01% 1856
2024
Q3
$43K Buy
6,046
+1,121
+23% +$10.3K ﹤0.01% 1855
2024
Q2
$55.9K Buy
4,925
+78
+2% +$779 ﹤0.01% 1780
2024
Q1
$41.6K Hold
4,847
﹤0.01% 1859
2023
Q4
$63.8K Buy
4,847
+1,811
+60% +$25K ﹤0.01% 1856
2023
Q3
$41.5K Hold
3,036
﹤0.01% 1888
2023
Q2
$42.4K Hold
3,036
﹤0.01% 1914
2023
Q1
$48K Hold
3,036
﹤0.01% 1889
2022
Q4
$50.1K Sell
3,036
-1,148
-27% -$20K ﹤0.01% 1702
2022
Q3
$90K Buy
+4,184
New +$104K ﹤0.01% 1577

Other funds holding HLF

Amundi's HLF Position: Q2 2025 in Review

Amundi sold out of Herbalife (HLF) in Q2 2025, closing a stake of 6,046 shares — an estimated $51.1K sold.

Amundi first reported a position in HLF in Q3 2022 and held it in 11 quarters. The position peaked at $90K in Q3 2022. 210 funds tracked by Wall St. Rank hold HLF as of Q2 2025.

  • Amundi reported no remaining Herbalife position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 6,046 Herbalife shares in Q2 2025, an estimated $51.1K.
  • Amundi first reported a position in Herbalife in Q3 2022 and held it in 11 quarters.
  • Amundi's Herbalife position peaked at $90K in Q3 2022.
  • 210 funds tracked by Wall St. Rank held Herbalife as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.